VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer. (Q37951859)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

main subject

angiogenesis inhibitor

1 reference

alternative mRNA splicing, via spliceosome

inferred from title

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

Eny Maria Goloni-Bertollo

15 January 2020

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

A R C P Oliveira

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

E C Pavarino

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

2 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

363-370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-011-1073-2

15 January 2020

exact match

0 references

cites work

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Alternative splicing: multiple control mechanisms and involvement in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Angiogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

VEGF-A splicing: the key to anti-angiogenic therapeutics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Differential effects of hyperphosphorylation on splicing factor SRp55

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

SR proteins and splicing control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

The dynamics of a pre-mRNA splicing factor in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Vascular endothelial growth factor in eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Clinical implications of circulating angiogenic factors in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

The protein kinase Clk/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Regulation of angiogenesis by hypoxia: role of the HIF system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

The anti-angiogenic isoforms of VEGF in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Therapeutic potential of manipulating VEGF splice isoforms in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Angiogenesis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Phosphorylation-dependent and -independent nuclear import of RS domain-containing splicing factors and regulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1073-2

Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis

21 January 2018

1 reference

12 December 2020

Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor

1 reference

12 December 2020

Prognostic Value of Vascular Endothelial Growth Factor Tumor Tissue Content of Colorectal Cancer

1 reference

12 December 2020

VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia

1 reference

12 December 2020

Human Müller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor.

1 reference

12 December 2020

Prognostic value of vascular endothelial growth factor expression in gastric carcinoma

1 reference

12 December 2020

Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression

1 reference

12 December 2020

Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma

1 reference

12 December 2020

VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix

1 reference

12 December 2020

The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term

1 reference

12 December 2020

Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.

1 reference

12 December 2020

VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

12 December 2020

10.1007/S00432-011-1073-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045472%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference